Literature DB >> 25180857

Lymphogranuloma venereum in an Italian MSM: concurrent pharyngeal and rectal infection.

Claudio Foschi1, Andrea Filippini, Antonietta D'Antuono, Monica Compri, Francesca Macca, Nicoletta Banzola, Antonella Marangoni.   

Abstract

An Italian HIV-positive man having sex with men (MSM) attended the STIs Outpatients Clinic of Sant'Orsola Hospital in Bologna complaining of anal pain and constipation. According to patient's sexual history and repertoires, NAAT testing for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) was performed. Pharyngeal and anal swabs resulted positive for CT DNA detection and the following molecular genotyping identified a L2 serovar, coming to the final diagnosis of pharyngeal and rectal lymphogranuloma venereum (LGV) infection. After an antibiotic therapy with doxycycline 100 mg twice a day for 3 weeks, the patient completely recovered and the test of cure was negative for LGV infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25180857

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  3 in total

Review 1.  Approach to lymphogranuloma venereum.

Authors:  Patrick O'Byrne; Paul MacPherson; Stephane DeLaplante; Gila Metz; Andree Bourgault
Journal:  Can Fam Physician       Date:  2016-07       Impact factor: 3.275

2.  Evaluation of the Versant CT/GC DNA 1.0 assay (kPCR) for the detection of extra-genital Chlamydia trachomatis and Neisseria gonorrhoeae infections.

Authors:  Antonella Marangoni; Claudio Foschi; Paola Nardini; Monica Compri; Roberto Cevenini
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

3.  Inguinal and anorectal Lymphogranuloma Venereum: a case series from a sexually transmitted disease center in Rome, Italy.

Authors:  Alessandra Latini; Mauro Zaccarelli; Maria Grazia Paglia; Maria Gabriella Donà; Amalia Giglio; Domenico Moretto; Antonella Vulcano; Massimo Giuliani; Manuela Colafigli; Marina Ambrifi; Fulvia Pimpinelli; Antonio Cristaudo
Journal:  BMC Infect Dis       Date:  2017-06-02       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.